Johnson & Johnson

Recent News About Johnson & Johnson View More

From Legal Newsline

Tensions run high in OK opioid trial Thursday; State focuses on risk data J&J relied on

By Kayla Elder | May 31, 2019

NORMAN, Okla. (Legal Newsline) - Tensions ran high in court Thursday as the Oklahoma opioid trial continued, with defense attorney Larry Ottoway objecting throughout the day to opposing counsel's line of questioning directed at defense witness, business director for Janssen Pharmaceuticals Kimberly Deem-Eshleman.

From Legal Newsline

Father recounts loss of son in Oklahoma Johnson & Johnson opioid trial

By John Sammon | May 30, 2019

NORMAN, Okla. (Legal Newsline) – Fighting back tears, a father who lost his son to an opioid overdose recounted the nightmare during testimony in a trial alleging that Johnson & Johnson flooded the state with addictive drugs for profit.

From Legal Newsline

Hunter: Case is about abating 'worst' man-made crisis; J&J: Case is about damages - not abatement

By Kayla Elder | May 29, 2019

NORMAN, Okla. (Legal Newsline) - Admitting there is a high potential for abuse in opioid medications, Johnson & Johnson attorney Larry Ottaway said during opening arguments on Tuesday that physicians prescribing its medications Nucynta and Duragesic know this risk and have to know it to be licensed.

The Record Network